LACOSTIM Trademark

Trademark Overview


On Friday, June 6, 2025, a trademark application was filed for LACOSTIM with the United States Patent and Trademark Office. The USPTO has given the LACOSTIM trademark a serial number of 99222258. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, June 6, 2025. This trademark is owned by UTC Therapeutics (Shanghai) CO., LTD.. The LACOSTIM trademark is filed in the Pharmaceutical Products category with the following description:

Anti-cancer preparations; Human vaccine preparations; Tumor suppressing agents; Vaccine adjuvants; Cellular function activating agents for medical purposes; Pharmaceutical preparations for the treatment and prevention of cancer and autoimmune diseases; Clinical medical reagents; Biological preparations for the treatment of cancer and autoimmune diseases; Cells for medical or clinical use; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer and autoimmune diseases; Pharmaceutical preparations for suppressing tumors; Immunostimulants; Cytostatics for medical purposes; Medical preparations for the treatment of cancer and autoimmune diseases; Biochemical reagents for medical or veterinary purposes; Pharmaceutical preparations containing cultured cells for cancer and autoimmune diseases; Biopharmaceutical preparations for the treatment of cancer and autoimmune diseases; Antibodies for medical purposes; Biological reagen...
lacostim

General Information


Serial Number99222258
Word MarkLACOSTIM
Filing DateFriday, June 6, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, June 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAnti-cancer preparations; Human vaccine preparations; Tumor suppressing agents; Vaccine adjuvants; Cellular function activating agents for medical purposes; Pharmaceutical preparations for the treatment and prevention of cancer and autoimmune diseases; Clinical medical reagents; Biological preparations for the treatment of cancer and autoimmune diseases; Cells for medical or clinical use; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer and autoimmune diseases; Pharmaceutical preparations for suppressing tumors; Immunostimulants; Cytostatics for medical purposes; Medical preparations for the treatment of cancer and autoimmune diseases; Biochemical reagents for medical or veterinary purposes; Pharmaceutical preparations containing cultured cells for cancer and autoimmune diseases; Biopharmaceutical preparations for the treatment of cancer and autoimmune diseases; Antibodies for medical purposes; Biological reagents for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 6, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameUTC Therapeutics (Shanghai) CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressShanghai, 201318
CN

Trademark Events


Event DateEvent Description
Friday, June 6, 2025NEW APPLICATION ENTERED
Friday, June 6, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 6, 2025APPLICATION FILING RECEIPT MAILED